Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
A lawsuit by a group of herring fishermen upended 40 years of legal precedent regarding how federal agencies interpret statutes
How virtual reality technologies can support clinical laboratory education efforts and what leaders should know about implementation
Technology experts Jaswant S. Tony and Neil Hillen explain what both clinical labs and IT departments can gain from closer collaboration
How artificial intelligence models can help labs, clinicians, and patients communicate with one another more effectively
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
A laboratory safety expert shares the most common CLIA citations from recent lab inspections, and how your lab can avoid similar problems.
The choice of venue was likely inspired by the longstanding anti-regulatory stance of the state's federal judges.
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.